Skip to main content

Table 3 OHSS outcomes of high-risk treatment and control groups

From: Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

 

Treatment groups (n = 161)

Control group

Letrozole group

Mifepristone group

GnRH-ant group

Three-drug group

(n = 43)

(n = 51)

(n = 39)

(n = 28)

(n = 120)

Paracentesis (n)

7 (16.3 %)

9 (17.7 %)

7 (17.9 %)

4 (14.3 %)

21 (19.2 %)

Length of hospital stay(days)

7.0 ± 2.9

7.4 ± 2.5

7.1 ± 2.8

6.8 ± 2.1

7.3 ± 2.7

Severity of OHSS

     

 Mild (n)

24 (55.8 %)

26 (51.0 %)

19 (48.7 %)

15 (53.6 %)

65 (54.2 %)

 Moderate (n)

12 (27.9 %)

15 (29.4 %)

13 (33.3 %)

8 (25.0 %)

33 (27.5 %)

 Severe (n)

7 (16.3 %)

10 (19.6 %)

7 (18.0 %)

5 (17.9 %)

22 (18.3 %)

Complications (n)

0

0

0

0

1b

Luteal phase(days)a

10.9 ± 2.6

10.5 ± 1.9

10.7 ± 2.4

10.4 ± 2.3

11.2 ± 3.1

  1. Values are means ± SD unless otherwise stated. Values in parentheses are percentages. OHSS ovarian hyperstimulation syndrome, NS not statistically significant
  2. aLuteal phase = interval between oocyte retrieval and next menstrual cycle
  3. bOne patient experienced ovarian torsion
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us